Business / Tags / Drug

BUSINESS / NEWS Tue Apr 15, 2008 @ 8:14am neoform

BusinessWeek -- AstraZenaca's Crestor study finds that statins may help prevent heart attacks because they control inflammation, not because they lower cholesterol The idea that lowering cholesterol is the key to preventing heart attacks and cardiovascular disease has.. Read More

BUSINESS / NEWS Fri Jul 20, 2007 @ 11:24am neoform

CNN -- Nigerian government lawyers withdrew a $7 billion civil lawsuit against Pfizer Inc. on Friday, saying they have discovered new material and plan to file what they called an even stronger case against the U.S. drug maker. The government has accused Pfizer.. Read More

BUSINESS / NEWS Thu Nov 2, 2006 @ 8:14am neoform

Washington Post -- CVS Corp., the nation's second-largest drugstore chain, has agreed to acquire pharmacy-benefit manager Caremark Rx Inc. in a $22.5 billion deal that would create a company with unprecedented clout to bargain with drugmakers for lower prices... Read More

BUSINESS / NEWS Wed Jun 18, 2008 @ 8:13am neoform

BusinessWeek -- While not an all-out success, Phase II testing of a Wyeth-Elan treatment showed positive results in a subset of patients. Investors applauded The much anticipated results of a clinical trial of one of the more promising Alzheimer's drugs, released June.. Read More

BUSINESS / NEWS Mon Jun 2, 2008 @ 8:16am neoform

BusinessWeek -- AstraZeneca's Iressa took an FDA hit in 2005 as a lung cancer treatment, but a recent study showed its potential in breast cancer patients There may be a second life for Iressa, AstraZeneca's once-promising cancer drug that came to symbolize the hype s.. Read More

BUSINESS / NEWS Mon Jul 16, 2007 @ 1:48pm neoform

BusinessWeek -- Some members of Congress want to limit Big Pharma's ability to promote products directly to consumers. But the roadblocks are high If Representative Henry Waxman (D-Calif.) had his way, the little butterfly used to advertise the insomnia remedy Lunesta.. Read More

BUSINESS / NEWS Sat May 12, 2007 @ 2:48pm neoform

BusinessWeek -- The shares declined for a second day Friday after the FDA recommended a stronger warning label for the biotech's anemia drug Amgen (AMGN) shares continued to head lower on May 11 following a sell-off on the previous day after a Food and Drug Administra.. Read More

BUSINESS / NEWS Thu Mar 29, 2007 @ 8:15am neoform

BusinessWeek -- Five for the Money's latest look at one of the riskiest sectors of the market identifies a handful of promising drug development companies Maybe the only thing more nerve-racking than being a biotech investor is actually running one of the risk-laden o.. Read More

BUSINESS / NEWS Mon Mar 26, 2007 @ 10:18am neoform

BusinessWeek -- Shares fell Friday after the biotech announced unsuccessful clinical trial results for cancer drugs Amgen (AMGN) has been fighting to prove that its colon cancer drug Vectibix can help save patients who are using a chemotherapy treatment in combination.. Read More

BUSINESS / OPINION Fri Dec 22, 2006 @ 10:44am neoform

American Constitution Society Blog -- A report by the General Accounting Office concludes that current patent law discourages drug companies from developing new drugs by allowing them to make excessive profits through minor changes to existing pharmaceuticals. While pharmaceutical research a.. Read More

BUSINESS / NEWS Mon Dec 4, 2006 @ 7:49pm neoform

www.redherring.com -- Pfizer shares plunged almost 12 percent Monday after the world’s largest drug maker pulled the plug on what it hoped would be a potential blockbuster cholesterol medication... Read More